Grifols SA
MAD:GRF
Grifols SA
Additional Paid In Capital
Grifols SA
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Grifols SA
MAD:GRF
|
Additional Paid In Capital
€910.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Oryzon Genomics SA
MAD:ORY
|
Additional Paid In Capital
€92.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Pharma Mar SA
MAD:PHM
|
Additional Paid In Capital
€71.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-14%
|
|
Biotechnology Assets SA
MAD:BST
|
Additional Paid In Capital
€97m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
See Also
What is Grifols SA's Additional Paid In Capital?
Additional Paid In Capital
910.7m
EUR
Based on the financial report for Dec 31, 2023, Grifols SA's Additional Paid In Capital amounts to 910.7m EUR.
What is Grifols SA's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
0%
Over the last year, the Additional Paid In Capital growth was 0%.